TY  - JOUR
AU  - Gonzalez, A
AU  - Moniche, F
AU  - Cayuela, A
AU  - Garcia-Lozano, J R
AU  - Torrecillas, F
AU  - Escudero-Martinez, I
AU  - Gonzalez-Marcos, J R
AU  - Mayol, A
AU  - Montaner, J
PY  - 2015
DO  - 10.1016/j.ejvs.2015.09.020
UR  - http://hdl.handle.net/10668/9609
T2  - European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
AB  - Genetic background has been identified to be a major predictor of post-clopidogrel platelet inhibition in patients undergoing coronary stenting. However, there is a lack of data on clopidogrel response regarding genotype in patients undergoing carotid...
LA  - en
KW  - CYP2C19
KW  - Carotid artery stenting
KW  - Clopidogrel
KW  - Aged
KW  - Angioplasty
KW  - Blood Platelets
KW  - Carotid Artery Diseases
KW  - Clopidogrel
KW  - Cytochrome P-450 CYP2C19
KW  - Female
KW  - Gene Frequency
KW  - Genotype
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Pharmacogenetics
KW  - Phenotype
KW  - Platelet Activation
KW  - Platelet Aggregation Inhibitors
KW  - Polymorphism, Genetic
KW  - Purinergic P2Y Receptor Antagonists
KW  - Receptors, Purinergic P2Y12
KW  - Stents
KW  - Ticlopidine
KW  - Time Factors
KW  - Treatment Outcome
TI  - Effect of CYP2C19 Polymorphisms on the Platelet Response to Clopidogrel and Influence on the Effect of High Versus Standard Dose Clopidogrel in Carotid Artery Stenting.
TY  - research article
VL  - 51
ER  -